License the latest technology from Imperial College London
Technology available for licensing
Imperial College London is among the world’s leading research universities, and one of the few focused exclusively on Science, Technology, Engineering, Medicine and Business. Technology developed by Imperial’s world-leading researchers is protected and packaged by our expert commercialisation specialists.
Available technologies span all areas of research undertaken at Imperial. If your business is considering licensing technology, you can view available technologies and enquire directly through this site.
Browse technologies and innovations derived from research undertaken by academics at Imperial College London
Small molecule inhibitors with potential for use in the treatment of neurodegenerative diseases such as Huntington's disease, viral conditions such as HIV, and cancers
BWSQ is the leading tool for assessing benzodiazepine withdrawal symptoms, used in a number of clinical trials involving benzodiazepines.
A fully flexible, scalable and low-cost detection platform to sense multiple protein targets simultaneously by grafting specific sequences along the backbone of a double-stranded DNA carrier.
A novel system that measures voltage in tissue and differentiates cancerous from non-cancerous tissue.
Smart phone Ballistocardiography (BCG) is a novel measurement method that requires fewer sensors (≥ 1) placed above the heart. It measures the physical movement of the chest due to the heart beating rather than electrical signals measured by ECG
ENGINI is a next generation neural implant technology for brain machine interfaces (BMIs) applicable to both central and peripheral nervous system
Professor Molly Steven's Osteochondral Scaffold is a 3D fibrous scaffold that structurally mimics articular cartilage
SPARTA™: a comprehensive nanoparticle analysis platform based on Raman spectroscopy providing simultaneous size, composition, and functionalisation analysis
A novel and patented production method introducing carbon nanotubes (CNTs) to carbon fibre (CF) composites to give enhanced electrical, mechanical and electrical properties.
A simple, low-cost and scalable technology to fabricate solution-processed circularly polarised organic light-emitting diodes (CP-OLEDs).
Licensing and IP performance 2019/20
Imperial inventors submitted 250 invention disclosures to our IPC team during the year
Imperial College London's licensing portfolio comprises 244 licences
Imperial filed 137 patents (including PCT applications) during the year
Imperial's patent portfolio reached 331 patents during the year
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more
Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.